• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Canopy Growth Corporation - Common Shares (NQ:CGC)

    0.9384 +0.0107 (+1.15%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Canopy Growth Corporation - Common Shares

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    89 90 Next >
    News headline image
    Canopy Growth's Business Is Improving. So Why Isn't the Stock Performing Better? ↗
    Two long-standing issues continue to weigh on this cannabis stock. 
    Via The Motley Fool
    Topics Cannabis
    News headline image
    Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline
    From Canopy Growth Corporation
    Via Business Wire
    News headline image
    Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations
    From Canopy Growth Corporation
    Via Business Wire
    News headline image
    Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why. ↗
    Revenue is growing, but the cannabis company still has a lot to prove to investors. 
    Via The Motley Fool
    Topics Cannabis
    News headline image
    Should You Buy Canopy Growth Stock on the Rebound? ↗
    Canopy Growth benefited from growth across all its divisions in the first quarter of fiscal 2027, but does that make it a worthwhile investment? 
    Via The Motley Fool
    Topics Cannabis
    News headline image
    Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands? ↗
    The Canadian cannabis companies are both seeing strong growth, but one is a better buy right now. 
    Via The Motley Fool
    Topics Cannabis
    News headline image
    Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. ↗
    After a huge gold rush, the marijuana sector stumbled, and now consolidation is gaining momentum. 
    Via The Motley Fool
    Topics Cannabis
    News headline image
    Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now
    From Canopy Growth Corporation
    Via Business Wire
    News headline image
    Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target? ↗
    Cannabis consolidation appears to be accelerating. 
    Via The Motley Fool
    Topics Cannabis
    News headline image
    Canopy Growth (CGC) Q1 2027 Earnings Call Transcript ↗
    Revenue grew 13% as MTL integration and Polish market strength drove results. 
    Via The Motley Fool
    Topics Cannabis Earnings World Trade
    News headline image
    Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows
    From Canopy Growth Corporation
    Via Business Wire
    News headline image
    Will Canopy Growth Get Acquired? ↗
    Curaleaf is attempting to acquire Canopy Growth's rival, Aurora Cannabis, and there could be more consolidation to come in the industry. 
    Via The Motley Fool
    Topics Cannabis
    News headline image
    Canopy Growth Targets European Cannabis Expansion After MTL Deal and Cost Cuts ↗
    Canopy Growth (NASDAQ:CGC) is positioning itself for further expansion in medical cannabis, European markets and Canadian recreational cannabis after restructuring operations, reducing costs and... 
    Via MarketBeat
    Topics Cannabis Economy
    News headline image
    Canopy Growth: Penny Stock Purgatory -- or Cannabis Rebound in the Making? ↗
    The turnaround is becoming more believable. 
    Via The Motley Fool
    Topics Cannabis
    News headline image
    Why Rescheduling Might Not Move Canopy Growth's Stock as Much as You Think ↗
    Canopy Growth is a marijuana stock, but U.S. regulations aren't the main driver of its business. 
    Via The Motley Fool
    Topics Cannabis
    News headline image
    Canopy Growth Q1 Earnings Call Highlights ↗
    Canopy Growth (NASDAQ:CGC) reported first-quarter fiscal 2027 net revenue of C$81.2 million, up 13% from the prior-year period, as the company recorded year-over-year growth across its cannabis and... 
    Via MarketBeat
    Topics Cannabis Earnings
    News headline image
    Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses
    From Canopy Growth Corporation
    Via Business Wire
    News headline image
    Thinking About Buying Canopy Growth? You May Want to Wait for This 1 Thing to Happen First. ↗
    The next key catalyst for this cannabis stock lies in the hands of a U.S. Federal Government agency. 
    Via The Motley Fool
    Topics Cannabis Economy Government
    News headline image
    Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
    From Canopy Growth Corporation
    Via Business Wire
    News headline image
    Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
    From Canopy Growth Corporation
    Via Business Wire
    News headline image
    President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray ↗
    The president directed federal authorities to reschedule medical marijuana. 
    Via The Motley Fool
    Topics Cannabis Government
    News headline image
    Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value? ↗
    A lower stock price doesn't eliminate investment risk. 
    Via The Motley Fool
    Topics Cannabis
    News headline image
    Canopy Growth: Is Another Reverse Stock Split Inevitable? ↗
    Shares of the cannabis company have fallen below the $1 mark again. 
    Via The Motley Fool
    Topics Cannabis
    News headline image
    Could Canopy Growth Stock Deliver a 4X Gain? 1 Analyst Thinks So. ↗
    Be careful before bucking the bearish trend. 
    Via The Motley Fool
    Topics Cannabis
    News headline image
    Canopy Growth's Medical Marijuana Sales Are Soaring. Is the Beaten-Down Stock Ready to Rebound? ↗
    Canopy Growth's medical marijuana division had a great quarter, but the rest of the business wasn't so lucky. 
    Via The Motley Fool
    Topics Cannabis Economy
    News headline image
    Where Will Canopy Growth Be in 5 Years? ↗
    Canopy Growth is a much riskier stock than it was five years ago. 
    Via The Motley Fool
    Topics Cannabis Economy
    News headline image
    Canopy Growth Q4 Earnings Call Highlights ↗
    Canopy Growth (NASDAQ:CGC) reported higher fiscal fourth-quarter revenue and said it entered fiscal 2027 with a stronger balance sheet following a year of restructuring, cost cuts and the acquisition... 
    Via MarketBeat
    Topics Cannabis Earnings
    News headline image
    Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis
    From Canopy Growth Corporation
    Via Business Wire
    News headline image
    Canopy Growth Announces Claybourne’s Frosted Flyers Wins ‘Best Infused Pre-Roll' at 2026 Grow Up Awards
    From Canopy Growth Corporation
    Via Business Wire
    News headline image
    Canopy Growth Just Made a Big Acquisition: Game-Changer -- or Another Misstep? ↗
    It will likely be more of the same from here on out for this cannabis player. 
    Via The Motley Fool
    Topics Cannabis
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    89 90 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.